MANAGEMENT, SURVEILLANCE PATTERNS, AND COSTS ASSOCIATED WITH LOW-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Bree, Kelly
Shan, Yong
Hensley, Patrick
Lobo, Niyati
Hu, Chengrui
Tyler, Douglas
Chamie, Karim
Kamat, Ashish
Williams, Stephen
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP39-10
引用
收藏
页码：E669 / E669
页数：1
相关论文
共 50 条
  • [31] MANAGEMENT OF VARIANT HISTOLOGY IN NON-MUSCLE INVASIVE BLADDER CANCER
    Prado, Kris
    Greenberg, Daniel
    Zhang, Chiyuan
    Sun, Andrew
    Skinner, Eila
    JOURNAL OF UROLOGY, 2020, 203 : E263 - E263
  • [32] CUA guidelines on the management of non-muscle invasive bladder cancer
    Kassouf, Wassim
    Traboulsi, Samer L.
    Kulkarni, Girish S.
    Breau, Rodney H.
    Zlotta, Alexandre
    Fairey, Andrew
    So, Alan
    Lacombe, Louis
    Rendon, Ricardo
    Aprikian, Armen G.
    Siemens, D. Robert
    Izawa, Jonathan I.
    Black, Peter
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (9-10): : E690 - E704
  • [33] OPTIMIZING AN ORGANOID ASSAY FOR PREDICTING INTRAVESICAL THERAPY RESPONSE IN LOW-GRADE INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Joffe, Benjamin I.
    Christin, John R.
    Le Coz, Clementine
    Laplaca, Caroline
    DeCastro, G. Joel
    Anderson, Christopher B.
    McKiernan, James M.
    Shen, Michael
    Lenis, Andrew T.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1079 - E1080
  • [34] BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Su, Zhuo T.
    Mahon, Katherine
    Rezaee, Michael
    Patel, Sunil
    Townsend, Jeffrey
    Kates, Max
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1169 - E1170
  • [35] Risk Stratification of Nonmuscle Invasive Bladder Cancer and Innovative Approaches to Management of Ta Low-Grade Tumors
    Kim, Sung Han
    Lerner, Seth P. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) : 163 - +
  • [36] The importance of being grade 3 in primary non-muscle invasive bladder cancer
    Beijert, I. J.
    Oskar, O.
    Gardmark, T.
    Holmberg, L.
    Haggstrom, C.
    Johnston, A.
    Trail, M.
    Hamid, S.
    Dreyer, B. A.
    Padovani, L.
    Garau, R.
    Hasan, R.
    Ahmad, I.
    Hendry, D.
    Comperat, E. M.
    Burger, M.
    Gontero, P.
    Ribal, M. J.
    Van Der Kwast, T. H.
    Babjuk, M.
    Sylvester, R. J.
    Mariappan, P.
    Liedberg, F.
    Van Rhijn, B. W. G.
    EUROPEAN UROLOGY, 2024, 85 : S2145 - S2146
  • [37] The effect of tumor grade heterogeneity on recurrence in non-muscle invasive bladder cancer
    Ho, Patrick
    Moran, George W.
    Wang, Vinson
    Li, Gen
    Virk, Renu K.
    McKiernan, James M.
    Anderson, Christopher B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (02) : 60.e11 - 60.e16
  • [38] Low-Grade, Multiple, Ta Non-muscle-Invasive Bladder Tumors: Tumor Recurrence and Worsening Progression
    Nerli R.B.
    Ghagane S.C.
    Shankar K.
    Sanikop A.C.
    Hiremath M.B.
    Dixit N.S.
    Magadum L.
    Indian Journal of Surgical Oncology, 2018, 9 (2) : 157 - 161
  • [39] Aftercare of non-muscle invasive bladder cancer
    Schulz, G. B.
    Schlenker, B.
    Stief, C. G.
    UROLOGE, 2019, 58 (08): : 943 - 952
  • [40] Hyperthermia for non-muscle invasive bladder cancer
    Soria, Francesco
    Allasia, Marco
    Oderda, Marco
    Gontero, Paolo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (03) : 313 - 321
12345